Keynote Speakers

John Clinton
North American Head of Creative and Content

February 20, 1:30pm

John Clinton, a Vancouver native, is a senior communications executive who has had leadership roles in the advertising, public relations, marketing and media worlds. He began his career in advertising, working in two of the world’s largest advertising networks, J Walter Thompson and Grey Worldwide. While at JWT he held progressive positions until he led the company in Canada, Chicago, and ran the Kellogg’s global account. He followed that with a 9-year run as CEO of Grey Canada. His advertising work exposed him to some of the world’s biggest brands in DELL, Kraft, Kellogg’s, Pepsi and RIM.

John’s magazine publishing and digital publishing business experience at Transcontinental enabled him to work closely with the media community and some of the largest print brands in the country and most importantly, the ever-evolving world of digital media.

In 2011 he moved to Edelman where as CEO he successfully grew the Canadian business by bringing in a more integrated creative-lead approach to PR. In 2015 he took on the role of Head of Creative and Content for North America which has exposed him to the power of the brand narrative and the importance of getting the story right, telling it in the right channels, and making sure it has the ability to earn attention. He and his team of over 300 people help apply that to evolve, promote and protect many of North America’s largest brands including United Airlines, Home Depot and Canadian Pacific.

Clinton’s work as a board member has placed him in for profit and not for profit boards in both Canada and the United States.

Clinton is an accomplished sculptor whose work can be found in collections in Canada, the U.S. and Europe.

Dr. Allen Eaves, OBC, MD, PhD, FRCPC

President and CEO
STEMCELL Technologies Inc.

February 20, 7:00pm

Allen Eaves, OBC MD PhD FRCPC, was the Founding Director of the Terry Fox Laboratory for Cancer Research for 25 years (1981-06), and Head of Clinical Hematology at the University of British Columbia for 18 years (1985-2003). Currently as the Professor Emeritus of Hematology at UBC since 2006, he has devoted himself to building STEMCELL Technologies Inc., a company he founded in 1993 to provide standardized tissue culture reagents for regenerative medicine and those doing cancer and immunological research. Always profitable and with 96% of its sales outside of Canada, STEMCELL is now Canada’s largest biotech company with over 1000 employees and a global network of sales offices and distribution centers serving thousands of customers.

Dr. Eaves has published over 200 papers in leading peer-review scientific journals. He has been elected as President of the International Society of Cell Therapy; President of the American Society of Blood and Marrow Transplantation; founding Treasurer of the Foundation for the Accreditation of Cell Therapy; and has been a member of Health Canada’s Expert Working Group on the Safety of Organs and Tissues for Transplantation. He sits on the boards of the Canadian Stem Cell Network, Canadian Stem Cell Foundation, Centre for Commercialization of Regenerative Medicine, and the Banff International Research Station for Mathematical Innovation and Discovery. He is passionate about providing excellent tools and reagents for researchers, and creating rewarding employment for those who love science.